Showing 21 - 30 of 33,008
pharmacy-level price data pertaining to over 800 drugs has been released weekly on the Medicare Web site continuously between … a large sample of pharmacy level drug price data collected from the Medicare website for several weeks to answer the …
Persistent link: https://www.econbiz.de/10012734948
Fair competition law and public health law talk past each other when discussing pharmaceutical pricing and distribution. The former cannot agree on the relevant definition of consumer welfare. The latter does not fully comprehend the highly complex but inherently collective nature of...
Persistent link: https://www.econbiz.de/10012957647
In a field experiment in Uganda, we find that demand after a free distribution of three health products is lower than after a sale distribution. This contrasts with work on insecticide-treated bed nets, highlighting the importance of product characteristics in determining pricing policy. We put...
Persistent link: https://www.econbiz.de/10013053653
In a field experiment in Uganda, we find that demand after a free distribution of three health products is lower than after a sale distribution. This contrasts with work on insecticide-treated bed nets, highlighting the importance of product characteristics in determining pricing policy. We put...
Persistent link: https://www.econbiz.de/10013020435
Reference price regimes for prescription drugs are usually implemented with the aim of curbing public expenditure with …-pay the difference between the drug's pharmacy retail price and the reimbursement level. Relying on a detailed product …-in-differences analysis show that branded products (without patent protection) affected by the policy change increased their prices. The price …
Persistent link: https://www.econbiz.de/10012827731
large sample of pharmacy-level drug price data collected from the Medicare website for several weeks indicate that the … be reconciled with models of dynamic price competition with consumer switching costs as in Klemperer (1987a,b). The …
Persistent link: https://www.econbiz.de/10012714541
-effectiveness analysis in reimbursement decisions helps to relate the reimbursement price paid to the social value of the product, but does … not necessarily result in the lowest possible price.The generic substitution policy has enabled Sweden to achieve fairly …
Persistent link: https://www.econbiz.de/10012447076
Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare...
Persistent link: https://www.econbiz.de/10011586604
Health care markets often lack a market force because the presence of health insurance undermines price signals …, Switzerland introduced out-of-pocket price differentiation. As of July 1st 2011, substitutable pharmaceuticals with prices above a … predefined threshold were subject to 20% coinsurance instead of the regular 10% coinsurance rate. Using comprehensive price data …
Persistent link: https://www.econbiz.de/10014551351
This paper models different external reference pricing schemes -- a price cap based on the drug price in one or two … countries and on the minimum or average drug price -- in a three-country framework. It studies the choice of external reference … under the minimum price-rule or under the average price-rule. External reference pricing increases the drug price and …
Persistent link: https://www.econbiz.de/10012998253